Investigating how specialized proteasomes affect Alzheimer's disease and aging
The Role of Immunoproteasome Function in Alzheimer's Disease and Aging
This study is looking at how a special type of protein recycler in the brain, called immunoproteasomes, works in people with Alzheimer's disease and as we age, to see if they help deal with inflammation and stress in brain cells, which could lead to new treatments for the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10884105 on NIH RePORTER |
What this research studies
This research explores the role of immunoproteasomes, a specialized type of proteasome, in the context of Alzheimer's disease (AD) and aging. It examines how these proteasomes, which are more efficient at degrading proteins than their constitutive counterparts, respond to inflammatory signals and oxidative stress in glial cells. By understanding the mechanisms behind immunoproteasome activity, the research aims to clarify their potential role in the progression of AD and whether they serve as a compensatory response to neuroinflammation. Patients may benefit from insights that could lead to new therapeutic strategies targeting these proteasomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those experiencing cognitive decline associated with aging.
Not a fit: Patients with early-stage Alzheimer's disease or those without any cognitive impairment may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding the role of proteasomes in neurodegenerative diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Myeku, Natura — Columbia University Health Sciences
- Study coordinator: Myeku, Natura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.